Web Notifications

SaltWire.com would like to send you notifications for breaking news alerts.

Activate notifications?

BeiGene lung cancer treatment meets main goal in late-stage study

STORY CONTINUES BELOW THESE SALTWIRE VIDEOS

Olive Tapenade & Vinho Verde | SaltWire

Watch on YouTube: "Olive Tapenade & Vinho Verde | SaltWire"

(Reuters) - BeiGene Ltd said on Tuesday its cancer therapy combination for treating lung cancer in previously untreated patients met the main goal in a late-stage study.

The therapy, tislelizumab, when administered in combination with chemotherapy helped reduce the risk of cancer progression in patients with squamous non-small cell lung cancer.

(Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shounak Dasgupta)

Share story:
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT